Friday, 20 November 2026

Pharmacists seek recognition in census forms
Open Access

Pharmacists seek recognition in census forms

Pharmacists seek recognition as a distinct category in census forms for individuals with pharmacy qualifications.

By Yulia Puspitasari  •  November 19, 2026
Read More



Pharmacists seek recognition in census forms
Open Access

Pharmacists seek recognition in census forms

Pharmacists seek recognition as a distinct category in census forms for individuals with pharmacy qualifications.

By Yulia Puspitasari  •  19/11/2026
HDFC Mutual Fund launches cancer charity drive
Open Access

HDFC Mutual Fund launches cancer charity drive

HDFC Mutual Fund launches cancer charity drive to help underprivileged cancer patients through the HDFC Charity Fund.

By Rara Setiawati  •  18/11/2026
India’s Pharmacy Graduates Push for Clinical Roles in Hospitals
Study Abstracts

India’s Pharmacy Graduates Push for Clinical Roles in Hospitals

India's pharmacy graduates seek clinical roles in hospitals, pushing beyond retail sales to ensure rational drug therapy and…

By Cika Rahardjo  •  17/11/2026
FDA Approves New Bladder Cancer Treatment Before Surgery
Study Abstracts

FDA Approves New Bladder Cancer Treatment Before Surgery

The FDA has approved a new bladder cancer treatment combining durvalumab and enfortumab vedotin, reducing recurrence risk by…

By Cika Rahardjo  •  16/11/2026
AI and treatment gaps worsen CLL care disparities
Research Briefs

AI and treatment gaps worsen CLL care disparities

AI and treatment gaps worsen disparities in CLL care, leaving minority and rural patients less likely to receive…

By Cika Rahardjo  •  14/11/2026
Food Cost Management: How Restaurant Owners Can Protect Profit Without Compromising Quality
Open Access

Food Cost Management: How Restaurant Owners Can Protect Profit Without Compromising Quality

Running a restaurant is not just about serving delicious food. Behind every popular menu item is a business…

By Rara Setiawati  •  14/11/2026
New Treatment Cuts Death Risk in Advanced Lung Cancer
Journal Drops

New Treatment Cuts Death Risk in Advanced Lung Cancer

New treatment cuts death risk in advanced lung cancer by over 8 months, according to a phase 3…

By Yulia Puspitasari  •  13/11/2026
Insurance rules limit access to new COPD biologics
Research Briefs

Insurance rules limit access to new COPD biologics

Insurance policies now restrict access to new COPD biologics, limiting treatment options for patients with eosinophilic COPD despite…

By Cika Rahardjo  •  12/11/2026
New obesity drug passes key heart safety test
Research Briefs

New obesity drug passes key heart safety test

Survodutide passes key heart safety test in phase 3 trial for high-risk obesity patients, marking first dual agonist…

By Yulia Puspitasari  •  11/11/2026
Lung Cancer Treatment Shifts to Immune Therapies
Research Briefs

Lung Cancer Treatment Shifts to Immune Therapies

Lung cancer treatment has shifted to immune therapies over the last 20 years, replacing cytotoxic chemotherapy with checkpoint…

By Cika Rahardjo  •  10/11/2026